p53 must be competent for transcriptional regulation to suppress tumor formation
- 7 March 2005
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 24 (22) , 3563-3573
- https://doi.org/10.1038/sj.onc.1208354
Abstract
In vitro studies suggest that effective tumor suppression by p53 requires multiple domains to execute transcription-dependent and transcription-independent functions. We generated a mutant p53 allele in mice, p53W25QL26S (p53QS), containing an inactive transactivation domain to evaluate the importance of transactivation for p53-mediated tumor suppression. Recently, we discovered that the allele also contains a valine substitution for alanine at codon 135, which borders the DNA-binding domain. We found that p53QSval135 bound to chromatin albeit less well than p53QSala135, but both were equally deficient in transcriptional regulation, apoptosis induction in mouse embryo fibroblasts (MEFs), and suppression of tumor formation by E1A, Ha-Ras transformed MEFs. p53QSval135 mice and p53-null mice exhibited identical tumor development kinetics and spectra in spontaneous and oncogene-initiated tumorigenicity assays, when tested in a homo- and heterozygous configuration. The p53QSval135 allele did not have dominant negative functions and behaved as a null allele. Taken together, these data indicate that effective tumor suppression requires the transcriptional regulation function of p53, and they suggest that transactivation independent functions of p53 are unlikely to contribute significantly to tumor suppression in vivo.Keywords
This publication has 51 references indexed in Scilit:
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activityOncogene, 1999
- Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formationThe EMBO Journal, 1998
- p53 Protein Exhibits 3′-to-5′ Exonuclease ActivityCell, 1996
- A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53–deficient miceNature Genetics, 1995
- Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.Genes & Development, 1994
- Tumor spectrum analysis in p53-mutant miceCurrent Biology, 1994
- The p53 tumour suppressor geneNature, 1991
- Temperature-dependent switching between “wild-type” and “mutant” forms of p53-Val135Journal of Molecular Biology, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989